Akira Nishiyama

Kagawa University

Papers

1

Total Citations

9

H-Index

1

About

Akira Nishiyama is a leading figure in renal and cardiovascular pharmacology, with a career dedicated to unraveling the molecular mechanisms of kidney injury and hypertension. His research focuses on the renin-angiotensin system, oxidative stress, and the pathophysiology of ischemia-reperfusion (IR) injury. A notable contribution includes his work on protease-activated receptor 1 (PAR1) in renal IR injury, where he demonstrated that PAR1 activation exacerbates microcirculation failure and tubular damage—a finding with direct implications for improving outcomes in renal transplantation and partial nephrectomy. With over 9 citations on this specific study, his broader body of work has garnered significant attention, reflecting his impact on understanding how vascular and inflammatory pathways converge in acute kidney injury. Nishiyama’s research has advanced therapeutic strategies targeting receptor-mediated injury, earning him recognition as a key contributor to nephrology and pharmacology. His investigations continue to bridge basic science and clinical application, making him a vital resource for students and researchers exploring kidney disease, hypertension, and organ protection.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
[Retracted] Protease‐Activated Receptor 1 Contributes to Microcirculation Failure and Tubular Damage in Renal Ischemia‐Reperfusion Injury in Mice
9 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Kagawa University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago